Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun

Dec 05 2018

• By Joseph Haas, Ian Haydock, Anju Ghangurde, and Jung Won Shin

DealWatch_1200x675

Related Content

Allergan's Botox Holds Its Own In Migraine, Despite CGRP Competition

Oct 31 2018

UPDATED: Clear 'Yes' From Shareholders On Takeda/Shire Deal

Dec 05 2018

Medical Aesthetics: A Untapped Pharma Market With Incoming Competition

Nov 30 2018

Deal Watch: BioCryst Shareholder Dissent Scuttles Planned Merger With Idera

Jul 13 2018

Sun Taps Mitsubishi For Ex-Novartis Japan Portfolio

Sep 07 2016

Related Companies

Revance Therapeutics, Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Allergan plc

ABL Bio Corp.

TRIGR Therapeutics, Inc

AbbVie Inc.

OncoMed Pharmaceuticals, Inc.

Sun Pharmaceutical Industries Ltd.

Novartis AG

Mitsubishi Tanabe Pharma Corporation

Apollomics, Inc.

Bristol Myers Squibb Company

Merck & Co., Inc.

Genor Biopharma Co. Ltd.

FUJIFILM Holdings Corp.

Advanced Accelerator Applications SA

Telix Pharmaceuticals Limited

Nihon Medi-Physics Co., Ltd.

Hikma Pharmaceuticals plc

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Asia Pacific Deals Commercial Business Strategies M & A BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.